BIZARRE: 4 | Mind Blowing Facts

Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings

Cardinal Health Inc (NYSE:CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52 Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion. The pharmaceutical segment increased 17% to $41 billion, driven primarily by branded pharmaceutical sales growth from large…

Benzinga · May 5, 2022

Cardinal Health: Q3 Earnings Insights

  Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Benzinga · May 3, 2022

This Favorable Sign Appears On Cardinal Health's Chart

If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga · Mar 10, 2022

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga · Feb 25, 2022

Expert Ratings For Cardinal Health

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga · Feb 4, 2022

Where Cardinal Health Stands With Analysts

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga · Feb 4, 2022

Cardinal Health's Return on Invested Capital Insights

According to Benzinga Pro data Cardinal Health (NYSE:CAH) posted a 81.99% decrease in earnings from Q1. Sales, however, increased by 3.39% over the previous quarter to $45.46 billion.

Benzinga · Feb 4, 2022

Cardinal Health's Q4 Earnings Hit By Inflationary Impacts, Supply Chain Constraints; Lowers FY22 Outlook

Cardinal Health (NYSE: CAH) has reported Q2 FY22 adjuste

Benzinga · Feb 3, 2022

Recap: Cardinal Health Q2 Earnings

  Cardinal Health (NYSE:CAH) reported its Q2 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 3, 2022